You can read the full November 6th print issue of Chain Drug Review in its entirety here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!
DEERFIELD, Ill. — Innovation is the lifeline of mass market beauty. There are significant changes in how innovation is generated, researched and applied, according to participants in a Chain Drug Review roundtable. Walgreens beauty and personal care executives joined several beauty brands for an in-depth discussion probing how to keep up with the ever-changing world
The Agile Innovation Series focuses on the need for organizations to constantly evolve and innovate with an agile mindset to remain viable in today’s dynamic world. Throughout the series accelerate360’s Trey Holder explores the current business environment through interviews with leaders in a variety of fields. This month, Holder caught up with Tom Furphy, chief
“There’s a crack in everything — that’s how the light gets in” — Leonard Cohen The last three years have witnessed a dramatic and to some degree unprecedented (and therefore unmodel-able) shift in shopping behavior. Much has been made of habit disruption due to COVID, and a thoroughly overrated assessment of the impact of COVID
Birds do it. Bees do it. Humans have been doing it since the beginning of time. And according to Maslow, along with food and breathing, it’s considered a fundamental need. Why then, does sexual wellness remain one of the more immature CPG categories out there? And for those products that successfully make it to an
As almost everybody knows by now, Packy Nespeca passed away, at age 100, in early October. To once again restate (and paraphrase) the age-old cliché: To those who knew Packy, no explanation is necessary; to those who did not, no explanation is possible. Rather than once again recall Packy’s adventuresome and highly accomplished life, we
CHICAGO — Speaking earlier this month at the Health Equity Summit presented by Kearney and Chain Drug Review, Dr. David Ansell brought the vexing problem of persistent health disparities in the U.S. into sharp focus. Based in part on his extensive experience delivering care to members of underserved communities, Ansell pointed to a startling fact
